Newsfeeds - Spark Newswire

1 minute read

Precigen Q2 EPS $(0.10) Beats $(0.12) Estimate, Sales $33.58M Beat $21.07M Estimate

Today, 6:49 AM

Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 61.54 percent increase over losses of $(0.26) per share from the same

PGEN

14 minute read

Earnings Scheduled For August 9, 2021

By Benzinga Insights

Today, 6:49 AM

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.

ACM

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 6:49 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

1 minute read

News

Precigen Insights: Return On Capital Employed

By Benzinga Insights

Today, 6:49 AM

During Q1, Precigen (NASDAQ:PGEN) brought in sales totaling $24.51 million. However, earnings decreased 598.82%, resulting in a loss of $17.69 million. Precigen reached earnings of $3.55 million and sales of $19.33 million in Q4.

PGEN

1 minute read

Legal
News

Precigen Granted U.S. Patent Titled ‘Expression of novel cell tags’

By Benzinga Newsdesk

Today, 6:49 AM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5317&f=G&l=50&d=PTXT&p=107&S1=20210615&OS=20210615&RS=20210615

PGEN

4 minute read

46 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 6:49 AM

Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share.

AEHL

1 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 6:49 AM

AXLA

4 minute read

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts

By Shanthi Rexaline

Today, 6:49 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10)

ALKS

3 minute read

28 Stocks Moving in Friday’s Pre-Market Session

By Lisa Levin

Today, 6:49 AM

Gainers Amesite Inc. (NASDAQ: AMST) rose 138% to $6.60 in pre-market trading after surging over 25% on Thursday.

AEMD

1 minute read

Precigen Stock Surges On Positive AG019 Data for Chronic Treatment Of Type 1 Diabetes

By Vandana Singh

Today, 6:49 AM

Precigen Inc’s (NASDAQ:PGEN) subsidiary Precigen ActoBio announced topline results from the Phase 1b/2a study evaluating AG019 ActoBiotics to treat recent-onset type…

PGEN